Trial Profile
A study evaluating effect liraglutide in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 22 Feb 2017 New trial record